Patents by Inventor Max KANARSKY

Max KANARSKY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10758739
    Abstract: Brain dysfunction can be treated by restructuring neural pathways in the brain. A desired area in the brain to form a new neural pathway is selected. The area receives a sequential combination of (1) transcranial photobiomodulation therapy (PBMT) including a series of pulses having a frequency matched to a target brain wave and (2) another transcranial stimulation (e.g., transcranial direct current electrical stimulation and/or transcranial magnetic stimulation). The different stimulation mechanisms ensure that neuroplasticity occurs to restructure a neural pathway that is dysfunctional in nature to a new neural pathway that conducts normally.
    Type: Grant
    Filed: May 18, 2018
    Date of Patent: September 1, 2020
    Assignee: MULTI RADIANCE MEDICAL
    Inventors: Douglas Johnson, Max Kanarsky
  • Patent number: 10744341
    Abstract: Disorders of the eye can be treated by photobiomodulation therapy according to a device designed to direct light into a patient's eye, no matter the configuration of the eye. The device, including a printed circuit board that includes an array of light delivery devices and a heat sink lens, can be placed proximal to the patient's eye. The light delivery devices can be powered to generate light. The light can be directed into the patient's eye regardless of a position of the patient's eye.
    Type: Grant
    Filed: August 2, 2018
    Date of Patent: August 18, 2020
    Assignee: MULTI RADIANCE MEDICAL
    Inventors: Douglas Johnson, Max Kanarsky, Larry W. Finn, Ian Dwayne Campbell, Jeffrey A. Lenk, Michael T. Barrett, Scott R. Lenk
  • Patent number: 10744337
    Abstract: Photobiomodulation therapy (PBMT) can be applied to a tender area on a subject's body to treat fibromyalgia. A light source device can be contacted to a subject's skin proximal to a tender area on the subject's body. A light signal (with wavelengths from the red to infrared part of the spectrum) can be applied in at least one of a pulsed operating mode, a continuous operating mode, and a super-pulsed operating mode through the light source device to the tender area. The light signal is applied for a time sufficient to stimulate a phototherapeutic response in the tender area to treat fibromyalgia.
    Type: Grant
    Filed: April 13, 2018
    Date of Patent: August 18, 2020
    Assignee: MULTI RADIANCE MEDICAL
    Inventors: Douglas Johnson, Max Kanarsky, Ernesto Leal-Junior
  • Publication number: 20200086134
    Abstract: Photobiomodulation therapy (PBMT) can be applied to a tender area on a subject's body to treat fibromyalgia. A light source device can be contacted to a subject's skin proximal to a tender area on the subject's body. A light signal (with wavelengths from the red to infrared part of the spectrum) can be applied in at least one of a pulsed operating mode, a continuous operating mode, and a super-pulsed operating mode through the light source device to the tender area. The light signal is applied for a time sufficient to stimulate a phototherapeutic response in the tender area to treat fibromyalgia.
    Type: Application
    Filed: April 13, 2018
    Publication date: March 19, 2020
    Inventors: Douglas JOHNSON, Max KANARSKY, Ernesto LEAL-JUNIOR
  • Publication number: 20200086135
    Abstract: Disorders of the eye can be treated by photobiomodulation therapy according to a device designed to direct light into a patient's eye, no matter the configuration of the eye. The device, including a printed circuit board that includes an array of light delivery devices and a heat sink lens, can be placed proximal to the patient's eye. The light delivery devices can be powered to generate light. The light can be directed into the patient's eye regardless of a position of the patient's eye.
    Type: Application
    Filed: August 2, 2018
    Publication date: March 19, 2020
    Inventors: Douglas JOHNSON, Max KANARSKY, Larry W. FINN, Ian Dwayne CAMPBELL, Jeffrey A. LENK, Michael T. BARRETT, Scott R. LENK
  • Publication number: 20200069959
    Abstract: Brain dysfunction can be treated by restructuring neural pathways in the brain. A desired area in the brain to form a new neural pathway is selected. The area receives a sequential combination of (1) transcranial photobiomodulation therapy (PBMT) including a series of pulses having a frequency matched to a target brain wave and (2) another transcranial stimulation (e.g., transcranial direct current electrical stimulation and/or transcranial magnetic stimulation). The different stimulation mechanisms ensure that neuroplasticity occurs to restructure a neural pathway that is dysfunctional in nature to a new neural pathway that conducts normally.
    Type: Application
    Filed: May 18, 2018
    Publication date: March 5, 2020
    Inventors: Douglas JOHNSON, Max KANARSKY
  • Publication number: 20170128736
    Abstract: A method for preventing muscle fatigue induced by exercise in patients with chronic obstructive pulmonary disease is described herein. The method comprises the step of providing a therapeutic laser device, wherein the therapeutic laser device generates a constant magnetic field in combination with a plurality of pulsed lights having a plurality of wavelengths. The method further comprises administering phototherapy to a muscle prior to exercising the muscle by placing the therapeutic laser device in direct contact with skin proximate to the muscle at a plurality of skin sites and pulsing the plurality of lights based on predefined parameters.
    Type: Application
    Filed: November 9, 2015
    Publication date: May 11, 2017
    Inventors: Douglas JOHNSON, Max KANARSKY